1-3 of 3
Ce Shi, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combined Targeting of JAK2 with a Type II JAK2 Inhibitor and mTOR with a TOR Kinase Inhibitor Constitutes Synthetic Activity in JAK2-Driven Ph-like Acute Lymphoblastic Leukemia

Ce Shi, PhD, Lina Han, PhD, Qi Zhang, Kathryn G. Roberts, Eugene Park, Yoko Tabe, MD PhD, Rodrigo Omar Jacamo, PhD, Hong Mu, MD PhD, Shuo-Chieh Wu, Jin Zhou, Helen Ma, Zhihong Zeng, MD, Nitin Jain, MD, Elias J Jabbour, MD, Markus Muschen, MDPhD, Sarah K Tasian, MD, Charles G. Mullighan, MBBS, MSc, MD, David M. Weinstock, David Fruman, PhD, Marina Konopleva, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2529.
https://doi.org/10.1182/blood.V126.23.2529.2529
Published: 2015
Journal Articles

Mechanisms of Acquired Resistance to Venetoclax in Preclinical AML Models

Qi Zhang, Rongqing Pan, MS, Lina Han, PhD, Ce Shi, PhD, Stephen E. Kurtz, PhD, Hong Mu, MD PhD, Helen Ma, Michael Andreeff, MD PhD, Joel Leverson, PhD, Jeffrey W. Tyner, PhD, Yingchang Mi, MD PhD, Marina Konopleva, MD PhD
Journal: Blood
Blood (2015) 126 (23): 328.
https://doi.org/10.1182/blood.V126.23.328.328
Published: 2015
Journal Articles

Concomitantly Targeting BCL-2 with Venetoclax (ABT-199/GDC-0199) and MAPK Signaling with Cobimetinib (GDC-0973) in Acute Myeloid Leukemia Models

Lina Han, PhD, Qi Zhang, Ce Shi, PhD, Joel Leverson, PhD, Monique Dail, Darren C. Phillips, PhD, Jun Chen, MDPhD, Sha S Jin, Rodrigo Omar Jacamo, PhD, Naval Daver, MD, Elias J Jabbour, MD, Hagop M Kantarjian, MD, Michael Andreeff, MD PhD, Deepak Sampath, PhD, Marina Konopleva, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2544.
https://doi.org/10.1182/blood.V126.23.2544.2544
Published: 2015